Literature DB >> 33149269

Activation of arginase II by asymmetric dimethylarginine and homocysteine in hypertensive rats induced by hypoxia: a new model of nitric oxide synthesis regulation in hypertensive processes?

Vasthi López1, Elena Uribe2, Fernando A Moraga3.   

Abstract

In recent years, the increase in blood pressure at high altitudes has become an interesting topic among high-altitude researchers. In our animal studies using Wistar rats, we observed the existence of two rat populations that exhibit differential physiological responses during hypoxic exposure. These rats were classified as hypoxia-induced hypertensive rats and nonhypertensive rats. A decrease in nitric oxide levels was reported in different hypertension models associated with increased concentrations of asymmetric dimethylarginine (ADMA) and homocysteine, and we recently described an increase in arginase type II expression under hypoxia. ADMA and homocysteine decrease nitric oxide (NO) bioavailability; however, whether ADMA and homocysteine have a regulatory effect on arginase activity and therefore regulate another NO synthesis pathway is unknown. Therefore, the aim of this study was to measure basal ADMA and homocysteine levels in hypoxia-induced hypertensive rats and evaluate their effect on arginase II activity. Our results indicate that hypoxia-induced hypertensive rats presented lower nitric oxide concentrations than nonhypertensive rats, associated with higher concentrations of homocysteine and ADMA. Hypoxia-induced hypertensive rats also presented lower dimethylarginine dimethylaminohydrolase-2 and cystathionine β-synthase levels, which could explain the high ADMA and homocysteine levels. In addition, we observed that both homocysteine and ADMA had a significant effect on arginase II activation in the hypertensive rats. Therefore, we suggest that ADMA and homocysteine have dual regulatory effects on NO synthesis. The former has an inhibitory effect on eNOS, and the latter has a secondary activating effect on arginase II. We propose that arginase II is activated by AMDA and homocysteine in hypoxia-induced hypertensive rats.

Entities:  

Keywords:  Arginine; Dimethylarginine; Homocysteine; Hypertension; Hypoxia

Mesh:

Substances:

Year:  2020        PMID: 33149269     DOI: 10.1038/s41440-020-00574-1

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  37 in total

Review 1.  Nitric oxide deficiency and endothelial dysfunction in pulmonary arterial hypertension.

Authors:  James R Klinger; Steven H Abman; Mark T Gladwin
Journal:  Am J Respir Crit Care Med       Date:  2013-09-15       Impact factor: 21.405

2.  Increased levels and reduced catabolism of asymmetric and symmetric dimethylarginines in pulmonary hypertension.

Authors:  Soni Pullamsetti; Ladislau Kiss; Hossein Ardeschir Ghofrani; Robert Voswinckel; Peter Haredza; Walter Klepetko; Clemens Aigner; Ludger Fink; Jai Prakash Muyal; Norbert Weissmann; Friedrich Grimminger; Werner Seeger; Ralph Theo Schermuly
Journal:  FASEB J       Date:  2005-04-12       Impact factor: 5.191

3.  Effect of high-altitude exposure in the elderly: the Tenth Mountain Division study.

Authors:  B D Levine; J H Zuckerman; C R deFilippi
Journal:  Circulation       Date:  1997-08-19       Impact factor: 29.690

4.  Roles of accumulated endogenous nitric oxide synthase inhibitors, enhanced arginase activity, and attenuated nitric oxide synthase activity in endothelial cells for pulmonary hypertension in rats.

Authors:  Akihito Sasaki; Shouzaburoh Doi; Shuki Mizutani; Hiroshi Azuma
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-02-23       Impact factor: 5.464

5.  Metabolism of asymmetric dimethylarginines is regulated in the lung developmentally and with pulmonary hypertension induced by hypobaric hypoxia.

Authors:  Francesca I Arrigoni; Patrick Vallance; Sheila G Haworth; James M Leiper
Journal:  Circulation       Date:  2003-03-04       Impact factor: 29.690

6.  Epidemiological study of hypertension in natives of Spiti Valley in Himalayas and impact of hypobaric hypoxemia; a cross-sectional study.

Authors:  P C Negi; Rajeev Bhardwaj; Arvind Kandoria; Sanjeev Asotra; Neeraj Ganju; Rajeev Marwaha; Rajesh Sharma; Anubhav Kanwar
Journal:  J Assoc Physicians India       Date:  2012-06

7.  Changes in 24 h ambulatory blood pressure and effects of angiotensin II receptor blockade during acute and prolonged high-altitude exposure: a randomized clinical trial.

Authors:  Gianfranco Parati; Grzegorz Bilo; Andrea Faini; Barbara Bilo; Miriam Revera; Andrea Giuliano; Carolina Lombardi; Gianluca Caldara; Francesca Gregorini; Katarzyna Styczkiewicz; Antonella Zambon; Alberto Piperno; Pietro Amedeo Modesti; Piergiuseppe Agostoni; Giuseppe Mancia
Journal:  Eur Heart J       Date:  2014-08-26       Impact factor: 29.983

Review 8.  Endothelial function and hypertension.

Authors:  Ulf Landmesser; Helmut Drexler
Journal:  Curr Opin Cardiol       Date:  2007-07       Impact factor: 2.161

9.  Upregulation of arginase expression and activity in hypertensive rats exposed to chronic intermittent hypobaric hypoxia.

Authors:  Vasthi Lopez; Patricia Siques; Julio Brito; Carmen Vallejos; Nelson Naveas; Claudia Carvallo; Fabiola León-Velarde; Nelson Carvajal
Journal:  High Alt Med Biol       Date:  2009       Impact factor: 1.981

10.  Prevalence of hypertension at high altitude: cross-sectional survey in Ladakh, Northern India 2007-2011.

Authors:  Tsering Norboo; Tsering Stobdan; Norboo Tsering; Norboo Angchuk; Phunsog Tsering; Iqbal Ahmed; Tsewang Chorol; Vijay Kumar Sharma; Prasanna Reddy; Shashi Bala Singh; Yumi Kimura; Ryota Sakamoto; Eriko Fukutomi; Motonao Ishikawa; Kuniaki Suwa; Yasuyuki Kosaka; Mitsuhiro Nose; Takayoshi Yamaguchi; Toshihiro Tsukihara; Kozo Matsubayashi; Kuniaki Otsuka; Kiyohito Okumiya
Journal:  BMJ Open       Date:  2015-04-20       Impact factor: 2.692

View more
  2 in total

Review 1.  Arginase: shedding light on the mechanisms and opportunities in cardiovascular diseases.

Authors:  Zhuozhuo Li; Liwei Wang; Yuanyuan Ren; Yaoyao Huang; Wenxuan Liu; Ziwei Lv; Lu Qian; Yi Yu; Yuyan Xiong
Journal:  Cell Death Discov       Date:  2022-10-08

2.  Lower expression of Hsa_circRNA_102682 in diabetic hyperhomocysteinemia negatively related to creatinemia is associated with TGF-β and CTGF.

Authors:  Fei Hu; Wenxin Sha; Huixue Dai; Xiangwei Yang; Peng Hu; Yudong Chu; Xiaohui Qiu; Shizhong Bu
Journal:  J Clin Lab Anal       Date:  2021-07-23       Impact factor: 2.352

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.